Order intake totaling €3.32m for Q1, 2016
New projects signed and major change orders on existing contracts for an amount of €1.69M. New project awards for an amount of €1.63M.
MEDIAN Technologies (ALMDT), a leading medical imaging solutions and service provider for image interpretation and management in oncology, announced today that it has recorded €3.32M of order intake for Q1, 2016. This order intake breaks down in new projects awards for an amount of €1.63M and new contracts or change orders on already existing contracts for an amount of €1.69M.
New project awards include several multiple cancer indications Phase I and Phase II studies sponsored by a major German biotech company, new client of MEDIAN Technologies.
*A project award is a notification announcing that the company’s solution has been selected for a specific project. This should result in a signed contract within 18 months, subject to upstream clinical results.